
    
      The principle of TCV is similar to that of traditional microbial vaccination where attenuated
      infectious agents are used to stimulate protective immune responses. Because pathogentic
      autoreactive T cells are viewed as pathogens in T cell-mediated autoimmune diseases, they can
      be used, as a vaccine to prevent and treat the diseases in which they are able to induce.
    
  